Elicio Therapeutics Inc. - Asset Resilience Ratio

Latest as of March 2022: 22.84%

Elicio Therapeutics Inc. (ELTX) has an Asset Resilience Ratio of 22.84% as of March 2022. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check how strategically is Elicio Therapeutics Inc.'s equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets

$18.56 Million

Cash + Short-term Investments

Total Assets

$81.26 Million

All company assets

Resilience Assessment

Good

Financial Resilience Level

Asset Resilience Ratio Trend (None–None)

This chart shows how Elicio Therapeutics Inc.'s Asset Resilience Ratio has changed over time. See ELTX equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Elicio Therapeutics Inc.'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Elicio Therapeutics Inc. (ELTX) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	$0.00	0%
Short-term Investments	$18.56 Million	22.84%
Total Liquid Assets	$18.56 Million	22.84%

Asset Resilience Insights

Good Liquidity Position: Elicio Therapeutics Inc. maintains a healthy 22.84% of assets in liquid form.
This level provides good financial flexibility while maintaining productive asset deployment.
The company has significant short-term investments, indicating active treasury management.

Elicio Therapeutics Inc. Industry Peers by Asset Resilience Ratio

Compare Elicio Therapeutics Inc.'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Beijing Wantai Biological Pharmacy Enterprise Co Ltd SHG:603392	Biotechnology	11.64%
Amicus Therapeutics Inc NASDAQ:FOLD	Biotechnology	8.37%
China Resources Boya Bio pharmaceutical Group Co Ltd SHE:300294	Biotechnology	23.15%
Shouyao Holdings (Beijing) Co. Ltd. A SHG:688197	Biotechnology	82.25%
Jiangsu Sihuan Bioengineering Co Ltd SHE:000518	Biotechnology	0.03%
Yantai Zhenghai Bio-Tech Co Ltd SHE:300653	Biotechnology	56.48%
Jiangsu GDK Biotechnology Co Ltd SHG:688670	Biotechnology	9.82%

Annual Asset Resilience Ratio for Elicio Therapeutics Inc. (None–None)

The table below shows the annual Asset Resilience Ratio data for Elicio Therapeutics Inc..

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
No yearly data available.

pp = percentage points

About Elicio Therapeutics Inc.

NASDAQ:ELTX USA Biotechnology

Market Cap

$77.44 Million

Market Cap Rank

#20264 Global

#4544 in USA

Share Price

$4.14

Change (1 day)

+7.53%

52-Week Range

$2.76 - $14.85

All Time High

$257.40